Subcutaneous fat necrosis of the newborn is a rare condition in which patches of a baby’s fat tissue beneath the skin become inflamed and harden into firm nodules, typically within the first week or two of life. The nodules usually resolve on their own within a few months, but the condition demands close medical attention because it can trigger dangerously high calcium levels in the blood. Understanding the risk factors, the timeline, and what to watch for makes a real difference in catching complications early.
What the Nodules Look and Feel Like
The hallmark of subcutaneous fat necrosis is one or more hard, sometimes rubbery lumps just beneath the skin. They tend to be purplish or reddish in color and show up most often on the upper back, shoulders, cheeks, buttocks, and limbs.1PubMed Central. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology The overlying skin may look discolored or slightly swollen. In a multi-center study of babies who developed the condition after cooling therapy, the back was involved about 60% of the time, and the nodules were first noticed around the fourth day of life on average.2Journal of Perinatology. Incidence and risk factor profile for subcutaneous fat necrosis among newborns undergoing therapeutic hypothermia: a multi-center regional cohort
The lumps can range from a single small nodule to large plaques covering a wide area. They are not usually painful to the baby, although they can feel alarming to a parent or caregiver who discovers them. Some nodules sit deep enough that they are easier to feel than to see, which is one reason clinical suspicion matters when a newborn has known risk factors.
Why It Happens
Newborn fat tissue has an unusual composition compared to adult fat. It contains a higher proportion of saturated fatty acids, which have a higher melting point. When that fat is stressed by cold, low oxygen, or physical pressure, its crystallization threshold is easier to reach, and the fat cells can break down. The body then mounts an inflammatory response to clean up the damaged tissue, producing the firm nodules that define the condition.
A systematic review of case reports identified several recurring risk factors: birth asphyxia (oxygen deprivation around delivery), therapeutic hypothermia (the controlled cooling treatment used for babies with brain injury from oxygen loss), maternal gestational diabetes, maternal high blood pressure during pregnancy, and macrosomia, meaning a birth weight above roughly 4,000 grams or about 8.8 pounds.3PubMed Central. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology Therapeutic hypothermia has become one of the most commonly reported associations because it involves deliberately lowering a baby’s body temperature to protect the brain, which directly stresses the fat tissue at the same time.4Pediatrics. Subcutaneous Fat Necrosis After Moderate Therapeutic Hypothermia in Neonates
Among nearly 500 newborns who received therapeutic hypothermia at multiple centers between 2018 and 2022, the incidence of subcutaneous fat necrosis was about 4%.5Journal of Perinatology. Incidence and risk factor profile for subcutaneous fat necrosis among newborns undergoing therapeutic hypothermia: a multi-center regional cohort That is low enough to count as rare, but high enough that neonatal teams treating babies with cooling therapy actively watch for it. In an earlier national registry of over 1,200 cooled newborns, 12 cases were identified, and in every one the skin lesions appeared after the cooling period had ended, reinforcing the link between hypothermia exposure and subsequent fat damage.6Pediatrics. Subcutaneous Fat Necrosis After Moderate Therapeutic Hypothermia in Neonates
The Hypercalcemia Problem
The nodules themselves typically resolve without treatment, but the calcium spike they can trigger is the reason this diagnosis is taken seriously. Estimates of how many affected babies develop high blood calcium vary, and the range is wide. One source found that roughly half of infants with the condition go on to develop hypercalcemia within the first month of life.7Seminars in Fetal and Neonatal Medicine. Subcutaneous fat necrosis associated with hypercalcemia in neonates with neonatal encephalopathy treated with therapeutic hypothermia A retrospective study of 32 infants found an even higher rate, with 86% diagnosed with hypercalcemia, most of them showing peak calcium levels within the first 28 days.8PubMed. Subcutaneous fat necrosis of the newborn: A retrospective study of 32 infants and care algorithm The difference likely reflects how aggressively each center tests for calcium and which babies are included in the study. The bottom line is that hypercalcemia is common enough in these babies that routine calcium monitoring is standard practice.
The timing matters. The skin nodules tend to appear first, usually within the first three weeks, while the calcium elevation often shows up later, sometimes weeks after the lesions develop.9PubMed. Hypercalcemia in neonatal subcutaneous fat necrosis: A systematic review of risk factors, timing, and complications This lag means a baby can look stable with resolving skin nodules and still develop dangerously high calcium afterward. The retrospective study of 32 infants found that no patients in their cohort developed hypercalcemia after three months of age, so current recommendations call for calcium monitoring for at least three months once the diagnosis is made.10PubMed. Subcutaneous fat necrosis of the newborn: A retrospective study of 32 infants and care algorithm
How High Calcium Develops
The granulomatous inflammation inside the fat nodules is the culprit. When the body sends immune cells to clean up the damaged fat, those immune cells produce an enzyme that converts vitamin D into its most active form. This active vitamin D ramps up calcium absorption from the gut and pulls calcium from bone, flooding the bloodstream.11British Journal of Dermatology. Expression of 25‐hydroxyvitamin D3‐1α‐hydroxylase in subcutaneous fat necrosis The same mechanism shows up in other granulomatous diseases in adults, which is why the pattern was recognized relatively quickly once researchers looked for it.
If hypercalcemia goes undetected, it can cause kidney damage, including nephrocalcinosis, which is a buildup of calcium deposits in the kidneys. It can also cause poor feeding, irritability, vomiting, and in severe cases, cardiac problems. One case report described a baby with birth asphyxia who developed hypercalcemia along with calcium deposits in both kidneys.12PubMed Central. Subcutaneous fat necrosis in an infant with hypoxic ischaemic encephalopathy stage 3: an uncommon association Beyond hypercalcemia, rare complications like low platelet counts, high triglycerides, and low blood sugar have been reported in individual cases, though these are much less common.13PubMed. Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature
How It Is Diagnosed
Most of the time, the diagnosis is made clinically. A doctor who sees firm, discolored nodules on a newborn with a relevant history (difficult delivery, cooling therapy, large birth weight) can reach the diagnosis at the bedside. When the presentation is unclear or the nodules are in unusual locations, imaging can help. Ultrasound is the preferred tool because it gives good detail of the shallow tissue where these nodules sit, does not require sedation, and does not use radiation.14PubMed. Subcutaneous fat necrosis of the newborn: a pictorial essay of an under-recognized entity On ultrasound, the nodules typically appear as bright, well-defined areas within the subcutaneous fat layer, sometimes with shadowing from the calcified or crystallized material inside.
If the diagnosis is still uncertain, a tissue biopsy provides definitive confirmation. Under the microscope, the characteristic findings include fat cells that have broken down, with distinctive needle-shaped clefts left behind by crystallized fats, and a surrounding cluster of immune cells including giant cells.15PubMed Central. Subcutaneous Fat Necrosis of Newborn: An Atypical Presentation Biopsy is not always necessary if the clinical picture is straightforward, but it becomes valuable when the differential diagnosis includes other conditions or when nodules appear without the usual risk factors.
In rare cases, subcutaneous fat necrosis presents without visible skin changes at all, making the diagnosis easy to miss on physical examination alone. One report described severe hypercalcemia in a baby with no characteristic skin lesion initially visible, which delayed recognition until imaging and biopsy confirmed the diagnosis.16PubMed Central. The cause of severe hypercalcaemia resistant to pamidronate treatment: subcutaneous fat necrosis with no visible skin lesion Situations like this highlight why unexplained hypercalcemia in a newborn with relevant risk factors should prompt investigation even without obvious nodules.
Treatment and Monitoring
The skin nodules themselves rarely need specific treatment. They shrink and disappear over weeks to months, with most resolving within six months.17PubMed Central. Subcutaneous fat necrosis in newborns: a systematic literature review of case reports and model of pathophysiology The real management challenge is the hypercalcemia. When blood calcium rises above the normal range, treatment typically starts with intravenous fluids to dilute the calcium and encourage the kidneys to excrete more of it. Furosemide, a diuretic that also promotes calcium excretion, is commonly added. Corticosteroids are used to dampen the inflammatory process that is driving the vitamin D overproduction. For feeding, some infants are switched to a low-calcium formula to reduce how much calcium they absorb from the gut. In one study, these combined measures brought calcium back to normal in a median of about nine days, though in some cases it took over a month.18PubMed Central. Severe hypercalcemia due to subcutaneous fat necrosis: presentation, management and complications
When standard treatment fails to control calcium, bisphosphonates may be considered. These drugs, which are normally used in adults for osteoporosis, work by reducing the release of calcium from bone. Their use in newborns is still uncommon and studied mainly through individual case reports, but they have been effective in babies whose calcium did not respond adequately to hydration, diuretics, and steroids.19PubMed Central. Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report In one case, a single dose of pamidronate (a bisphosphonate) succeeded after other therapies had only partially lowered calcium, and it allowed the medical team to avoid prolonged steroid use. Cases of treatment-resistant hypercalcemia have also been reported, including one in which pamidronate itself did not fully resolve the problem, underscoring that severe cases require close specialist involvement.20PubMed Central. The cause of severe hypercalcaemia resistant to pamidronate treatment: subcutaneous fat necrosis with no visible skin lesion
After discharge, follow-up appointments generally include repeat blood calcium checks, and renal ultrasound may be performed to look for calcium deposits in the kidneys if levels were elevated. Most clinicians continue monitoring for at least three months, since hypercalcemia can emerge or recur during that window.
How It Differs From Sclerema Neonatorum
One condition that has caused historical confusion is sclerema neonatorum, a different and far more serious form of skin hardening in newborns. Where subcutaneous fat necrosis produces discrete, localized nodules in otherwise well or recovering babies, sclerema neonatorum causes diffuse, widespread hardening of the skin and underlying tissue across large portions of the body. It typically occurs in premature or severely ill infants and carries a high mortality rate. The distinction matters because the prognosis and management are very different.21PubMed. Sclerema neonatorum and subcutaneous fat necrosis of the newborn in the same infant
The confusion between these two conditions goes back decades. A 1933 paper on subcutaneous fat necrosis noted that British and American medical writers were still calling it “sclerema neonatorum” and that cases labeled as “scleroderma neonatorum” were in all probability fat necrosis as well.22JAMA Dermatology. SUBCUTANEOUS FAT NECROSIS OF THE NEW-BORN: REPORT OF FIVE CASES Histological and chemical analysis eventually separated the two, but the terminological overlap persisted in some textbooks for years afterward. Modern pathology draws a clear line between them, but the historical muddle is worth knowing about if you encounter older medical literature that uses the terms interchangeably.
Macrosomia, Smoking, and Other Emerging Risk Factors
Beyond the well-established links to birth asphyxia and therapeutic hypothermia, researchers have identified several other factors that appear to increase risk. In a systematic evaluation of 16 children with subcutaneous fat necrosis, macrosomia was present in nearly half, and exposure to maternal smoking during pregnancy, whether active or passive, was found in a substantial proportion of those who were assessed for it. The same study flagged known or suspected risk factors for blood clotting problems in the mother, father, or newborn, along with abnormal blood fat levels in some cases.23PubMed. Subcutaneous fat necrosis of the newborn: a systematic evaluation of risk factors, clinical manifestations, complications and outcome of 16 children
These findings are still based on small numbers, so they are better thought of as signals than established causes. But they hint that the condition may not always be a straightforward consequence of cooling or oxygen deprivation. Some babies may carry a metabolic susceptibility in the composition of their fat tissue or the way their clotting system works. Macrosomia in particular keeps showing up across different study groups, which makes sense biologically: larger babies have more subcutaneous fat, and that fat may be under greater mechanical stress during a difficult delivery.
The smoking connection is less intuitive and less studied. It is possible that maternal smoking alters fetal fat metabolism or blood vessel function in ways that make fat tissue more vulnerable to necrosis, but this remains speculative. For now, these emerging risk factors mainly serve as additional reasons to monitor certain babies closely rather than as targets for prevention.
What Parents Should Expect
For families going through this, the experience is often unsettling but ultimately reassuring. The nodules look worse than they are. They can appear suddenly and feel hard and immobile under the skin, which understandably triggers fear of something more serious. In the vast majority of cases, the lumps soften and flatten over weeks to a few months without any lasting mark on the skin.
The part that requires real vigilance is the calcium monitoring. Babies diagnosed with subcutaneous fat necrosis typically need blood draws at regular intervals to check calcium levels, even after the nodules have visibly improved. If calcium rises, the baby may need to be readmitted for treatment. Parents are usually told to watch for signs of high calcium such as poor feeding, excessive sleepiness, constipation, or unusual irritability, and to report those symptoms promptly. Once the monitoring window closes, usually after about three months, the risk fades and further follow-up depends on whether any kidney involvement was detected.
One common source of parental anxiety is whether the condition signals a broader health problem or will recur. Subcutaneous fat necrosis does not recur once it resolves, and it does not indicate an underlying genetic disorder in the typical case. It is a one-time reaction to a specific set of circumstances around birth. Babies who developed it after therapeutic hypothermia are already being followed for neurological outcomes related to the oxygen deprivation that led to cooling in the first place, and the fat necrosis itself does not add to that neurological risk. The condition is a complication of what happened at birth, not a predictor of future problems.